Frontiers in Oncology (Jan 2022)
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients
- Jun Li,
- Jun Li,
- Sile Han,
- Cuiyun Zhang,
- Cuiyun Zhang,
- Yanlin Luo,
- Li Wang,
- Ping Wang,
- Yi Wang,
- Qingxin Xia,
- Xiaoyan Wang,
- Xiaoyan Wang,
- Bing Wei,
- Bing Wei,
- Jie Ma,
- Jie Ma,
- Hongle Li,
- Hongle Li,
- Yongjun Guo,
- Yongjun Guo
Affiliations
- Jun Li
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Jun Li
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- Sile Han
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Cuiyun Zhang
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Cuiyun Zhang
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- Yanlin Luo
- Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Li Wang
- Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Ping Wang
- Department of Pathophysiology, School of Basic Medical Science, Zhengzhou University, Zhengzhou, China
- Yi Wang
- Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Qingxin Xia
- Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Xiaoyan Wang
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Xiaoyan Wang
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- Bing Wei
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Bing Wei
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- Jie Ma
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Jie Ma
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- Hongle Li
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Hongle Li
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- Yongjun Guo
- Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
- Yongjun Guo
- Henan Key Laboratory of Molecular Pathology, Zhengzhou, China
- DOI
- https://doi.org/10.3389/fonc.2021.840551
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
